Tech Company Financing Transactions

Meditrina Pharmaceuticals Funding Round

Michigan Economic Development Corporation participated in a $4.4 million Series A funding round for Meditrina Pharmaceuticals. The round was announced on 4/4/2007.

Transaction Overview

Announced On
4/4/2007
Transaction Type
Venture Equity
Amount
$4,400,000
Round
Series A
Proceeds Purpose
The proceeds will allow the company to continue funding its phase II clinical trials.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1190 Saratoga ave. 180
San Jose, CA 95129
USA
Email Address
Not Recorded
Overview
Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women's health disorders with unmet medical needs.
Profile
Meditrina Pharmaceuticals LinkedIn Company Profile
Social Media
Meditrina Pharmaceuticals Company Twitter Account
Company News
Meditrina Pharmaceuticals News
Facebook
Meditrina Pharmaceuticals on Facebook
YouTube
Meditrina Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Founder
Csaba Truckai
  Csaba Truckai LinkedIn Profile  Csaba Truckai Twitter Account  Csaba Truckai News  Csaba Truckai on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/4/2007: Firm58 venture capital transaction
Next: 4/4/2007: Biodiesel Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary